Core Viewpoint - Cosmos Health Inc. is evaluating strategic monetization options for its real estate portfolio to unlock shareholder value, highlighting a significant disconnect between its market capitalization and the intrinsic value of its assets [1][12][14] Real Estate Valuation - The combined fair market value of the Company's Cana Laboratories manufacturing facility and CosmoFarm logistics center is estimated at approximately $15 million, excluding machinery and equipment [2] - The estimated value is supported by favorable macro conditions in the Greek property market, with residential property prices surpassing their 2008 pre-financial crisis peak and commercial real estate experiencing sustained growth [3] - The fair market value of the Company's real estate assets exceeds its current market capitalization of approximately $13.5 million as of February 17, 2026 [4] Property Details - The Cana Laboratories property spans approximately 54,000 square feet of land with a constructed area of about 35,700 square feet, allowing for additional buildable capacity subject to approvals [7] - The property is strategically located in Neo Iraklio, Athens, providing access to major transport routes and proximity to commercial centers [8] - The CosmoFarm Logistics Center consists of approximately 29,100 square feet and operates as a pharmaceutical wholesale and distribution hub, featuring advanced automation systems [11] Strategic Options - The Company is considering various monetization strategies, including outright sale, joint ventures, and sale-leaseback transactions, which could generate proceeds comparable to or exceeding its current public float [12][13] - Proceeds from potential monetization may be utilized for debt reduction, reinvestment in core initiatives, acquisitions, or enhancing shareholder value [13] Management Perspective - The CEO of Cosmos Health emphasized the disconnect between the Company's valuation and the intrinsic value of its assets, indicating that monetizing non-core real estate could unlock substantial value [14]